November 2022
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
This conference discussed the priorities for tackling overprescribing in the NHS, looking at progress since NHS England’s overprescribing review and subsequent Good for You, Good for Us, Good for Everybody action plan.
It brought together stakeholders and policymakers to assess what more is needed if the plan’s aims for systemic and cultural change are to be achieved.
The conference was an opportunity to assess priorities for the new Secretary of State in supporting initiatives to tackle overprescribing, as well as assessing indications of policy direction so far - including proposals in Our Plan for Patients for increased prescribing powers for pharmacists.
There was also discussion on the future of medicines optimisation, opportunities for social prescribing, and measures to enable consistent delivery across the whole population and to expand the workforce to deliver non-medical treatments where possible.
Key areas for discussion included:
- culture change: including development of leadership and accountability around overprescribing at national and ICS level - key issues for the Clinical Director for Prescribing
- systemic change: the role of social prescribing - strategic priorities for medicines optimisation - practicalities of scaling up including funding, staffing, training, and engagement with patients
- patient-centred care: practical steps - involving patients with managing long-term conditions - building support and frameworks required for development
- research: sharing best practice and guidance - building the evidence base - developing understanding of the groups most impacted
- digital: the role of digital transformation in supporting patient-centred care and the ability to make more informed care decisions - improvements to patient records
- pharma: system-wide collaboration and industry transparency
We are pleased to have been able to include keynote sessions with: Professor Tony Avery, GP; Professor of Primary Health Care, University of Nottingham; and National Clinical Director for Prescribing, NHS England; Dr Michael Dixon, Chair, College of Medicine; Co-chair, National Social Prescribing Network; and Visiting Professor, University College London and Westminster University; Katherine Le Bosquet, Associate Chief Pharmacist Clinical Services, Princess Royal University Hospital; and Clinical Adviser to the Overprescribing Review; Dr Amit Aggarwal, Executive Director, Medical Affairs, ABPI; and Nick Kaye, Vice-Chair, National Pharmacy Association.
The conference was an opportunity for stakeholders to consider the issues alongside key policy officials who attended from DHSC; the DCMS; and The Scottish Government.
